AstraZeneca to acquire Neogene Therapeutics, accelerating ambition in Oncology cell therapy AstraZeneca today announced an agreement to acquire Neogene Therapeutics Inc. (Neogene), a global clinical-stage biotechnology company pioneering the discovery, development and manufacturing of next-generation T-cell receptor therapies (TCR-Ts) that…
Merck Announces First-Quarter 2023 Dividend RAHWAY, N.J.–(BUSINESS WIRE)– Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that the Board of Directors has declared a quarterly dividend of $0.73 per share of the company’s…
New global survey reveals opportunities to address organ damage risk with people living with lupus earlier in the course of their disease In findings from a new global survey, nearly half (44%) of the expert healthcare professionals (HCPs) surveyed across…
AMGEN TO WEBCAST INVESTOR CALL AT WCIRDC 2022 Amgen (NASDAQ: AMGN) will host a webcast call for the investment community in conjunction with the World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease (WCIRDC) at 8:00 a.m. ET on Monday, Dec. 5, 2022. David M. Reese,…
WHO recommends a new name for monkeypox disease Following a series of consultations with global experts, WHO will begin using a new preferred term “mpox” as a synonym for monkeypox. Both names will be used simultaneously for one year while…
Focus on capacity building at WHO’s Global School on Refugee and Migrant Health in Dhaka Globally one in eight or over one billion people today are migrants with 281 million international migrants and many million individuals who are stateless. Climate…
Gilead and Arcus Biosciences Announce Positive Update on Joint TIGIT Program From Interim Analysis of ARC-7 Study in Non-Small Cell Lung Cancer FOSTER CITY, Calif. & HAYWARD, Calif.–(BUSINESS WIRE)– Gilead Sciences, Inc. (Nasdaq: GILD) and Arcus Biosciences (NYSE: RCUS) today…
Sanofi moves into its new Paris global headquarters Sanofi has moved into its new global headquarters in the 17th arrondissement of Paris, at 46-48 Avenue de la Grande Armée. The 9,000m² sites have been designed to foster new hybrid ways of…
Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference NEW YORK–(BUSINESS WIRE)– Pfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to a webcast of a discussion with Angela…
Quadripartite welcomes new political commitments in the fight against antimicrobial resistance The Third Global High-Level Ministerial Conference on Antimicrobial Resistance, hosted in Muscat, Oman, concluded today, where targets to address the global antimicrobial resistance (AMR) challenge were discussed for the first…
AI tailors artificial DNA for future drug development With the help of an AI, researchers at Chalmers University of Technology, Sweden, have succeeded in designing synthetic DNA that controls the cells’ protein production. The technology can contribute to the development…
Remdesivir reduces COVID-19 mortality in a real-world setting The COVID-19 pandemic has led to an explosion of clinical research resulting in the development of a variety of vaccines and treatments, although the efficacy of some remains controversial. Now, researchers from…